₦ NGN
Language
Currency
‹ All headlines
ScienceDaily Health

CRISPR makes prostate cancer vulnerable to immunotherapy

2 days ago
Scientists used CRISPR to make prostate cancer cells easier for the immune system to detect and destroy. The experimental treatment dramatically improved the effects of immunotherapy in mice and may offer hope for other hard-to-treat tumors.
Get the EPELCON App v3.6.0
Invest, Learn & Earn on the go
Download APK
feedback Feedback